...

首页> 外文期刊>Cancer: A Journal of the American Cancer Society >Agencies join forces to boost the number of veterans in cancer clinical trials A new program is helping to make National Cancer Institute-sponsored trials more accessible to a vulnerable population

【24h】

Agencies join forces to boost the number of veterans in cancer clinical trials A new program is helping to make National Cancer Institute-sponsored trials more accessible to a vulnerable population

机译：机构加入癌症临床试验中的退伍军人人数，新计划有助于使国家癌症研究所赞助的试验更易受伤害的人群

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Cancer: A Journal of the American Cancer Society》 |2019年第12期|共2页
作者
Printz Carrie;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Agencies join forces to boost the number of veterans in cancer clinical trials A new program is helping to make National Cancer Institute-sponsored trials more accessible to a vulnerable population [J] . Printz Carrie Cancer: A Journal of the American Cancer Society . 2019,第12期

机译：机构加入癌症临床试验中的退伍军人人数，新计划有助于使国家癌症研究所赞助的试验更易受伤害的人群
2. Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program [J] . Minasian Lori M., Tangen Catherine M., Wickerham Lawrence Seminars in Oncology . 2015,第5期

机译：国家癌症研究所资助的社区预防肿瘤临床试验中的数据和标本的持续使用
3. Approaches to phase 1 clinical trial design focused on safety, efficiency, and selected patient populations: a report from the clinical trial design task force of the national cancer institute investigational drug steering committee. [J] . Ivy SP, Siu LL, Garrett Mayer Clinical cancer research: an official journal of the American Association for Cancer Research . 2010,第6期

机译：阶段1临床试验设计的方法侧重于安全性，效率和选定的患者人群：国家癌症研究所研究药物指导委员会临床试验设计工作组的报告。
4. DO CANCER CLINICAL TRIAL POPULATIONS TRULY REPRESENT CANCER PATIENTS? A COMPARISON OF OPEN CLINICAL TRIALS TO THE CANCER GENOME ATLAS [C] . NOPHARGEIFMAN, ATUL J.BUTTE Pacific Symposium on Biocomputing . 2016

机译：癌症临床试验群体真正代表癌症患者吗？对癌症基因组阿特拉斯公开临床试验的比较
5. Clinical predictive value of pre-clinical cancer models: A study of the predictive value of the in vitro cell line, human xenograft and murine allograft pre-clinical cancer models for phase II clinical trials of cytotoxic cancer drugs [D] . Voskoglou-Nomikos, Theodora 2001

机译：临床前癌症模型的临床预测价值：体外细胞系，人异种移植和小鼠同种异体移植临床前癌症模型对细胞毒性癌症药物II期临床试验的预测价值研究
6. Approaches to Phase 1 Clinical Trial Design Focused on Safety Efficiency and Selected Patient Populations: A Report from the Clinical Trial Design Task Force of the National Cancer Institute Investigational Drug Steering Committee [O] . S. Percy Ivy, Lillian L. Siu, Elizabeth Garrett-Mayer, -1

机译：途径1期临床试验设计方面的安全效率和选择的患者人群：从美国国家癌症研究所调查药物指导委员会的临床试验设计工作组报告
7. Agencies join forces to boost the number of veterans in cancer clinical trials [O] . Carrie Printz 2019

机译：机构联手促进癌症临床试验中的退伍军人人数
8. Restructuring the National Cancer Clinical Trials Enterprise. Report of the Clinical Trials Working Group of the National Cancer Advisory Board. [R] . 2005

机译：重组国家癌症临床试验企业。国家癌症咨询委员会临床试验工作组的报告。

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号